Mesenchymal stem cells: New insights into tissue engineering and regenerative medicine

Fundamentals of Tissue Engineering and Regenerative Medicine

Volumn , Issue , 2009, Pages 177-195

  Djouad, Farida ^a   Tuan, Rocky S ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895363863     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-77755-7_15     Document Type: Chapter

References (191)

1. Friedenstein AJ, Chailakhyan RK, Gerasimov UV (1987) Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20:263-272
2. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA (1980) Characterization of human bone marrow fbroblast colony-forming cells (CFU-F) and their progeny. Blood 56:289-301
3. Bruder SP, Jaiswal N, Haynesworth SE (1997) Growth kinetics, self-renewal, and the osteogenic potential of pu-rifed human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294
4. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
5. Kolf CM, Cho E, Tuan RS (2007) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204
6. Kemp KC, Hows J, Donaldson C (2005) Bone marrow-derived mesenchymal stem cells. Leuk Lymphoma 46:1531-1544
7. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T (2005) Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 52:2521-2529
8. Dazzi F, Ramasamy R, Glennie S, Jones SP, Roberts I (2006) The role of mesenchymal stem cells in haemopoiesis. Blood Rev 20:161-171
9. Zhu H, Mitsuhashi N, Klein A, Barsky LW, Weinberg K, Barr M L, Demetriou A, Wu GD (2006) The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 24:928-935
10. Boiret N, Rapatel C, Veyrat-Masson R, Guillouard L, Guerin JJ, Pigeon P, Descamps S, Boisgard S, Berger MG (2005) Characterization of nonexpanded mesenchy-mal progenitor cells from normal adult human bone marrow. Exp Hematol 33:219-225
11. Jackson L, Jones DR, Scotting P, Sottile V (2007) Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med 53:121-127
12. Buhring HJ, Battula VL, Treml S, Schewe B, Kanz L, Vogel W (2007) Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 1106:262-271
13. Simmons PJ, Torok-Storb B (1991) Identifcation of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78:55-62
14. Dennis JE, Carbillet JP, Caplan AI, Charbord P (2002) The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs 170:73-82
15. Docheva D, Popov C, Mutschler W, Schieker M (2007) Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system. J Cell Mol Med 11:21-38
16. Ip JE, Wu Y, Huang J, Zhang L, Pratt RE, Dzau VJ (2007) Mesenchymal stem cells utilize integrin beta1 not CX chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell 18:2873-2882
17. Whetton AD, Graham GJ (1999) Homing and mobilization in the stem cell niche. Trends Cell Biol 9:233-238
18. Wagner W, Wein F, Roderburg C, Saffrich R, Faber A, Krause U, Schubert M, Benes V, Eckstein V, Maul H, Ho AD (2007) Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction. Exp Hematol 35:314-325
19. Liu Y, Jovanovic B, Pins M, Lee C, Bergan RC (2002) Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. On-cogene 21:8272-8281
20. Arai F, Ohneda O, Miyamoto T, Zhang XQ, Suda T (2002) Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med 195:1549-1563
21. Bruder SP, Ricalton NS, Boynton RE, Connolly TJ, Jaiswal N, Zaia J, Barry FP (1998) Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteo-genic differentiation. J Bone Miner Res 13:655-663
22. Schieker M, Pautke C, Haasters F, Schieker J, Docheva D, Bocker W, Guelkan H, Neth P, Jochum M, Mutschler W (2007) Human mesenchymal stem cells at the single-cell level: simultaneous seven-colour immunofuorescence. J Anat 210:592-599
23. Takeichi M, Inuzuka H, Shimamura K, Fujimori T, Na-gafuchi A (1990) Cadherin subclasses: differential expression and their roles in neural morphogenesis. Cold Spring Harb Symp Quant Biol 55:319-325
24. Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345-357
25. Vleminckx K, Kemler R (1999) Cadherins and tissue formation: integrating adhesion and signaling. Bioessays 21:211-220
26. Stains JP, Civitelli R (2005) Cell-cell interactions in regulating osteogenesis and osteoblast function. Birth Defects Res C Embryo Today 75:72-80
27. Modarresi R, Lafond T, Roman-Blas JA, Danielson KG, Tuan RS, Seghatoleslami MR (2005) N-cadherin mediated distribution of beta-catenin alters MAP kinase and BMP-2 signaling on chondrogenesis-related gene expression. J Cell Biochem 95:53-63
28. DeLise AM, Tuan RS (2002) Alterations in the spatiotemporal expression pattern and function of N-cadherin inhibit cellular condensation and chondrogenesis of limb mesenchymal cells in vitro. J Cell Biochem 87:342-359
29. Marie PJ (2002) Role of N-cadherin in bone formation. J Cell Physiol 190:297-305
30. Phinney DG, Prockop DJ (2007) Concise review: mesen-chymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair current views. Stem Cells 25:2896-2902
31. Aslan H, Zilberman Y, Kandel L, Liebergall M, Oskouian RJ, Gazit D, Gazit Z (2006) Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 24:1728-1737
32. Muraglia A, Cancedda R, Quarto R (2000) Clonal mes-enchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113:1161-1166
33. Kopen GC, Prockop DJ, Phinney DG (1999) Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96:10711-10716
34. Wislet-Gendebien S, Hans G, Leprince P, Rigo JM, Moonen G, Rogister B (2005) Plasticity of cultured mes-enchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 23:392-402
35. Cho KJ, Trzaska KA, Greco SJ, McArdle J, Wang FS, Ye JH, Rameshwar P (2005) Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells 23:383-391
36. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleo-mycin exposure and ameliorates its fbrotic effects. Proc Natl Acad Sci U S A 100:8407-8411
37. Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC, Fine A (2001) Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128:5181-5188
38. Spees JL, Olson SD, Ylostalo J, Lynch PJ, Smith J, Perry A, Peister A, Wang MY, Prockop DJ (2003) Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci U S A 100:2397-2402
39. Duffeld JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, Ichimura T, Bonventre JV (2005) Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115:1743-1755
40. Ma Y, Xu Y, Xiao Z, Yang W, Zhang C, Song E, Du Y, Li L (2006) Reconstruction of chemically burned rat cor-neal surface by bone marrow-derived human mesenchy-mal stem cells. Stem Cells 24:315-321
41. DeLise AM, Fischer L, Tuan RS (2000) Cellular interactions and signaling in cartilage development. Osteoar-thritis Cartilage 8:309-334
42. Kirsch T, von der Mark K (1991) Ca2+ binding properties of type X collagen. FEBS Lett 294:149-152
43. Kirsch T, Ishikawa Y, Mwale F, Wuthier RE (1994) Roles of the nucleational core complex and collagens (types II and X) in calcifcation of growth plate cartilage matrix vesicles. J Biol Chem 269:20103-20109
44. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ (2002) In vitro cartilage formation by human adult stem cells from bone marrow stroma defnes the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci U S A 99:4397-4402
45. Barry F, Boynton R E, Liu B, Murphy JM (2001) Chon-drogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components. Exp Cell Res 268:189-200
46. Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H, Weber RM, Ewerbeck V, Richter W (2003) Cartilagelike gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum 48:418-429
47. Zou H, Choe KM, Lu Y, Massague J, Niswander L (1997) BMP signaling and vertebrate limb development. Cold Spring Harb Symp Quant Biol 62:269-272
48. Mehra A, Wrana JL (2002) TGF-beta and the Smad signal transduction pathway. Biochem Cell Biol 80:605-622
49. Candia AF, Watabe T, Hawley SH, Onichtchouk D, Zhang Y, Derynck R, Niehrs C, Cho KW (1997) Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development 124:4467-4480
50. Xu D, Gechtman Z, Hughes A, Collins A, Dodds R, Cui X, Jolliffe L, Higgins L, Murphy A, Farrell F (2006) Potential involvement of BMP receptor type IB activation in a synergistic effect of chondrogenic promotion between rhTGFbeta3 and rhGDF5 or rhBMP7 in human mesenchymal stem cells. Growth Factors 24:268-278
51. Zhang W, Ge W, Li C, You S, Liao L, Han Q, Deng W, Zhao RC (2004) Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 13:263-271
52. Goldring MB, Tsuchimochi K, Ijiri K (2006) The control of chondrogenesis. J Cell Biochem 97:33-44
53. Musgrave DS, Pruchnic R, Bosch P, Ziran BH, Whalen J, Huard J (2002) Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. J Bone Joint Surg Br 84:120-127
54. Satija NK, Gurudutta GU, Sharma S, Afrin F, Gupta P, Verma YK, Singh VK, Tripathi RP (2007) Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev 16:7-23
55. Ryoo HM, Lee MH, Kim YJ (2006) Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 366:51-57
56. Hu G, Lee H, Price SM, Shen MM, Abate-Shen C (2001) Msx homeobox genes inhibit differentiation through up-regulation of cyclin D1. Development 128:2373-2384
57. Friedman MS, Long MW, Hankenson KD (2006) Osteo-genic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 98:538-554
58. Avram MM, Avram AS, James WD (2007) Subcutaneous fat in normal and diseased states 3. Adipogenesis: from stem cell to fat cell. J Am Acad Dermatol 56:472-942
59. Chuang CC, Yang RS, Tsai KS, Ho FM, Liu SH (2007) Hyperglycemia enhances adipogenic induction of lipid accumulation: involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and peroxisome proliferator-activated receptor gamma signaling. Endocrinology 148:4267-4275
60. Rodriguez JP, Montecinos L, Rios S, Reyes P, Martinez J (2000) Mesenchymal stem cells from osteoporotic patients produce a type I collagen-defcient extracellular matrix favoring adipogenic differentiation. J Cell Bio-chem 79:557-565
61. Nuttall ME, Gimble JM (2000) Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27:177-184
62. Rickard DJ, Wang FL, Rodriguez-Rojas AM, Wu Z, Trice WJ, Hoffman SJ, Votta B, Stroup GB, Kumar S, Nuttall ME (2006) Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone 39:1361-1372
63. Knutsen G, Engebretsen L, Ludvigsen TC, Drogset JO, Grontvedt T, Solheim E, Strand T, Roberts S, Isaksen V, Johansen O (2004) Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am 86-A:455-464
64. Blevins FT, Steadman JR, Rodrigo JJ, Silliman J (1998) Treatment of articular cartilage defects in athletes: an analysis of functional outcome and lesion appearance. Orthopedics 21:761-767; discussion 767-768
65. Buckwalter JA, Mankin HJ (1998) Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 47:487-504
66. Knutsen G, Drogset JO, Engebretsen L, Grontvedt T, Isaksen V, Ludvigsen TC, Roberts S, Solheim E, Strand T, Johansen O (2007) A randomized trial comparing autolo-gous chondrocyte implantation with microfracture. Findings at fve years. J Bone Joint Surg Am 89:2105-2112
67. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L (1994) Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331:889-895
68. Roberts S, Hollander AP, Caterson B, Menage J, Richardson JB (2001) Matrix turnover in human cartilage repair tissue in autologous chondrocyte implantation. Arthritis Rheum 44:2586-2598
69. Thirion S, Berenbaum F (2004) Culture and phenotyping of chondrocytes in primary culture. Methods Mol Med 100:1-14
70. Stokes DG, Liu G, Coimbra IB, Piera-Velazquez S, Crowl RM, Jimenez SA (2002) Assessment of the gene expression profle of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum 46:404-419
71. Darling EM, Athanasiou KA (2005) Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res 23:425-432
72. Martin I, Vunjak-Novakovic G, Yang J, Langer R, Freed LE (1999) Mammalian chondrocytes expanded in the presence of fbroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Exp Cell Res 253:681-688
73. Darling EM, Athanasiou KA (2005) Retaining zonal chondrocyte phenotype by means of novel growth environments. Tissue Eng 11:395-403
74. Barbero A, Grogan SP, Mainil-Varlet P, Martin I (2006) Expansion on specifc substrates regulates the phenotype and differentiation capacity of human articular chondro-cytes. J Cell Biochem 98:1140-1149
75. Carver SE, Heath CA (1999) Infuence of intermittent pressure, fuid fow, and mixing on the regenerative properties of articular chondrocytes. Biotechnol Bioeng 65:274-281
76. Lee CR, Grodzinsky AJ, Hsu HP, Martin SD, Spector M (2000) Effects of harvest and selected cartilage repair procedures on the physical and biochemical properties of articular cartilage in the canine knee. J Orthop Res 18:790-799
77. Majumdar MK, Wang E, Morris EA (2001) BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol 189:275-284
78. Awad HA, Halvorsen YD, Gimble JM, Guilak F (2003) Effects of transforming growth factor beta1 and dex-amethasone on the growth and chondrogenic differentiation of adipose-derived stromal cells. Tissue Eng 9:1301-1312
79. Ma HL, Hung SC, Lin SY, Chen YL, Lo WH (2003) Chondrogenesis of human mesenchymal stem cells encapsulated in alginate beads. J Biomed Mater Res A 64:273-281
80. Erickson GR, Gimble JM, Franklin DM, Rice HE, Awad H, Guilak F (2002) Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun 290:763-769
81. Huang C Y, Reuben PM, D'Ippolito G, Schiller PC, Cheung HS (2004) Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture. Anat Rec A Discov Mol Cell Evol Biol 278:428-436
82. Awad HA, Wickham MQ, Leddy HA, Gimble JM, Gui-lak F (2004) Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials 25:3211-3222
83. Caterson EJ, Li WJ, Nesti LJ, Albert T, Danielson K, Tuan RS (2002) Polymer/alginate amalgam for cartilage-tissue engineering. Ann N Y Acad Sci 961:134-138
84. Li WJ, Laurencin CT, Caterson EJ, Tuan RS, Ko FK (2002) Electrospun nanofbrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res 60:613-621
85. Xu XL, Lou J, Tang T, Ng KW, Zhang J, Yu C, Dai K (2005) Evaluation of different scaffolds for BMP-2 genetic orthopedic tissue engineering. J Biomed Mater Res B Appl Biomater 75:289-303
86. Coleman RM, Case ND, Guldberg RE (2007) Hydrogel effects on bone marrow stromal cell response to chondro-genic growth factors. Biomaterials 28:2077-2086
87. Mauck RL, Yuan X, Tuan RS (2006) Chondrogenic differentiation and functional maturation of bovine mesen-chymal stem cells in long-term agarose culture. Osteoar-thritis Cartilage 14:179-189
88. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mi-zuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295
89. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Multi-lineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228
90. Dragoo JL, Samimi B, Zhu M, Hame SL, Thomas BJ, Lieberman JR, Hedrick MH, Benhaim P (2003) Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br 85:740-747
91. Chiou M, Xu Y, Longaker MT (2006) Mitogenic and chondrogenic effects of fbroblast growth factor-2 in adipose-derived mesenchymal cells. Biochem Biophys Res Commun 343:644-652
92. Lin Y, Luo E, Chen X, Liu L, Qiao J, Yan Z, Li Z, Tang W, Zheng X, Tian W (2005) Molecular and cellular characterization during chondrogenic differentiation of adipose tissue-derived stromal cells in vitro and cartilage formation in vivo. J Cell Mol Med 9:929-939
93. Masuoka K, Asazuma T, Hattori H, Yoshihara Y, Sato M, Matsumura K, Matsui T, Takase B, Nemoto K, Ishihara M (2006) Tissue engineering of articular cartilage with autologous cultured adipose tissue-derived stromal cells using atelocollagen honeycomb-shaped scaffold with a membrane sealing in rabbits. J Biomed Mater Res B Appl Biomater 79:25-34
94. Dragoo JL, Carlson G, McCormick F, Khan-Farooqi H, Zhu M, Zuk PA, Benhaim P (2007) Healing full-thickness cartilage defects using adipose-derived stem cells. Tissue Eng 13:1615-1621
95. Huang JI, Kazmi N, Durbhakula MM, Hering TM, Yoo JU, Johnstone B (2005) Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res 23:1383-1389
96. Yokoyama A, Sekiya I, Miyazaki K, Ichinose S, Hata Y, Muneta T (2005) In vitro cartilage formation of composites of synovium-derived mesenchymal stem cells with collagen gel. Cell Tissue Res 322:289-298
97. Park Y, Sugimoto M, Watrin A, Chiquet M, Hunziker E. B (2005) BMP-2 induces the expression of chondrocyte-specifc genes in bovine synovium-derived progenitor cells cultured in three-dimensional alginate hydrogel. Osteoarthritis Cartilage 13:527-536
98. Solchaga LA, Yoo JU, Lundberg M, Dennis JE, Hu-ibregtse BA, Goldberg VM, Caplan AI (2000) Hyaluro-nan-based polymers in the treatment of osteochondral defects. J Orthop Res 18:773-780
99. Solchaga LA, Temenoff JS, Gao J, Mikos AG, Caplan AI, Goldberg VM (2005) Repair of osteochondral defects with hyaluronan-and polyester-based scaffolds. Osteoarthritis Cartilage 13:297-309
100. Na K, Kim S, Woo DG, Sun BK, Yang HN, Chung HM, Park KH (2007) Synergistic effect of TGFbeta-3 on chondrogenic differentiation of rabbit chondrocytes in thermo-reversible hydrogel constructs blended with hy-aluronic acid by in vivo test. J Biotechnol 128:412-22
101. Williams CG, Kim TK, Taboas A, Malik A, Manson P, Elisseeff J (2003) In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymer-izing hydrogel. Tissue Eng 9:679-88
102. Li WJ, Danielson KG, Alexander PG, Tuan RS (2003) Biological response of chondrocytes cultured in three-dimensional nanofbrous poly(epsilon-caprolactone) scaffolds. J Biomed Mater Res A 67:1105-1114
103. Aigner J, Tegeler J, Hutzler P, Campoccia D, Pavesio A, Hammer C, Kastenbauer E, Naumann A (1998) Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mater Res 42:172-181
104. Hoshikawa A, Nakayama Y, Matsuda T, Oda H, Naka-mura K, Mabuchi K (2006) Encapsulation of chondro-cytes in photopolymerizable styrenated gelatin for cartilage tissue engineering. Tissue Eng 12:2333-2341
105. Kuo YC, Lin CY (2006) Effect of genipin-crosslinked chitin-chitosan scaffolds with hydroxyapatite modifca-tions on the cultivation of bovine knee chondrocytes. Biotechnol Bioeng 95:132-144
106. De Franceschi L, Grigolo B, Roseti L, Facchini A, Fini M, Giavaresi G, Tschon M, Giardino R (2005) Transplantation of chondrocytes seeded on collagen-based scaffold in cartilage defects in rabbits. J Biomed Mater Res A 75:612-622
107. Vinatier C, Magne D, Moreau A, Gauthier O, Malard O, Vignes-Colombeix C, Daculsi G, Weiss P, Guicheux J (2007) Engineering cartilage with human nasal chon-drocytes and a silanized hydroxypropyl methylcellulose hydrogel. J Biomed Mater Res A 80:66-74
108. Buschmann MD, Gluzband YA, Grodzinsky AJ, Kimura JH, Hunziker EB (1992) Chondrocytes in agarose culture synthesize a mechanically functional extracellular matrix. J Orthop Res 10:745-758
109. Balakrishnan B, Jayakrishnan A (2005) Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds. Biomaterials 26:3941-3951
110. Shin H, Quinten Ruhe P, Mikos AG, Jansen JA (2003) In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials 24:3201-3211
111. Galois L, Hutasse S, Cortial D, Rousseau CF, Grossin L, Ronziere MC, Herbage D, Freyria AM (2006) Bovine chondrocyte behaviour in three-dimensional type I collagen gel in terms of gel contraction, proliferation and gene expression. Biomaterials 27:79-90
112. Giannoni P, Siegrist M, Hunziker EB, Wong M (2003) The mechanosensitivity of cartilage oligomeric matrix protein (COMP). Biorheology 40:101-109
113. Wong M, Siegrist M, Gaschen V, Park Y, Graber W, Studer D (2002) Collagen fbrillogenesis by chondro-cytes in alginate. Tissue Eng 8 979-87.
114. Hung CT, Lima EG, Mauck RL, Takai E, LeRoux MA, Lu HH, Stark RG, Guo XE, Ateshian GA (2003) Anatomically shaped osteochondral constructs for articular cartilage repair. J Biomech 36:1853-1864
115. Knudson CB, Knudson W (2001) Cartilage proteogly-cans. Semin Cell Dev Biol 12:69-78
116. Liu Y, Shu XZ, Prestwich GD (2006) Osteochondral defect repair with autologous bone marrow-derived mesen-chymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng 12:3405-3416
117. Li WJ, Cooper JA Jr, Mauck RL, Tuan RS (2006) Fabrication and characterization of six electrospun poly(alpha-hydroxy ester)-based fbrous scaffolds for tissue engineering applications. Acta Biomater 2:377-385
118. Li WJ, Tuli R, Okafor C, Derfoul A, Danielson KG, Hall DJ, Tuan RS (2005) A three-dimensional nanofbrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 26:599-609
119. Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R (1996) Novel approach to fabricate porous sponges of poly(D, L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 17:1417-1422
120. Freed LE, Marquis JC, Nohria A, Emmanual J, Mikos AG, Langer R (1993) Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res 27:11-23
121. Chung C, Burdick JA (2008) Engineering cartilage tissue. Adv Drug Deliv Rev 60:243-262
122. Zwingmann J, Mehlhorn, AT, Sudkamp N, Stark B, Dauner M, Schmal H (2007) Chondrogenic differentiation of human articular chondrocytes differs in biodegradable PGA/PLA scaffolds. Tissue Eng 13:2335-2343
123. Sittinger M, Reitzel D, Dauner M, Hierlemann H, Hammer C, Kastenbauer E, Planck H, Burmester GR, Bujia J (1996) Resorbable polyesters in cartilage engineering: affnity and biocompatibility of polymer fber structures to chondrocytes. J Biomed Mater Res 33:57-63
124. Cao Y, Vacanti JP, Paige KT, Upton J, Vacanti CA (1997) Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg 100:297-302; discussion 303-304
125. Caterson EJ, Nesti LJ, Li WJ, Danielson KG, Albert TJ, Vaccaro AR, Tuan RS (2001) Three-dimensional cartilage formation by bone marrow-derived cells seeded in polylactide/alginate amalgam. J Biomed Mater Res 57:394-403
126. Jin XB, Sun YS, Zhang K, Wang J, Shi TP, Ju XD, Lou SQ (2007) Tissue engineered cartilage from hTGF beta2 transduced human adipose derived stem cells seeded in PLGA/alginate compound in vitro and in vivo. J Biomed Mater Res A (in press)
127. Choi NW, Cabodi M, Held B, Gleghorn JP, Bonassar LJ, Stroock AD (2007) Microfuidic scaffolds for tissue engineering. Nat Mater 6 908-15.
128. Heng BC, Cao T, Lee EH (2004) Directing stem cell differentiation into the chondrogenic lineage in vitro. Stem Cells 22:1152-1167
129. Sampath TK, Reddi AH (1981) Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci U S A 78:7599-7603
130. Urist MR, Mikulski A, Lietze A (1979) Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci U S A 76:1828-1832
131. Kaps C, Bramlage C, Smolian H, Haisch A, Ungethum U, Burmester GR, Sittinger M, Gross G, Haupl T (2002) Bone morphogenetic proteins promote cartilage differentiation and protect engineered artifcial cartilage from fbroblast invasion and destruction. Arthritis Rheum 46:149-162
132. Bailon-Plaza A, Lee AO, Veson EC, Farnum CE, van der Meulen MC (1999) BMP-5 defciency alters chondro-cytic activity in the mouse proximal tibial growth plate. Bone 24:211-216
133. Kameda T, Koike C, Saitoh K, Kuroiwa A, Iba H (2000) Analysis of cartilage maturation using micromass cultures of primary chondrocytes. Dev Growth Differ 42:229-236
134. Haaijman A, Burger EH, Goei SW, Nelles L, ten Dijke P, Huylebroeck D, Bronckers AL (2000) Correlation between ALK-6 (BMPR-IB) distribution and responsiveness to osteogenic protein-1 (BMP-7) in embryonic mouse bone rudiments. Growth Factors 17:177-192
135. Loeser RF, Chubinskaya S, Pacione C, Im HJ (2005) Basic fbroblast growth factor inhibits the anabolic activity of insulin-like growth factor 1 and osteogenic protein 1 in adult human articular chondrocytes. Arthritis Rheum 52:3910-3917
136. Frenkel SR, Saadeh PB, Mehrara BJ, Chin GS, Steinbrech DS, Brent B, Gittes GK, Longaker MT (2000) Transforming growth factor beta superfamily members: role in cartilage modeling. Plast Reconstr Surg 105:980-990
137. Sellers RS, Peluso D, Morris EA (1997) The effect of recombinant human bone morphogenetic protein-2 (rh-BMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Joint Surg Am 79:1452-1463
138. Sellers RS, Zhang R, Glasson SS, Kim HD, Peluso D, D'Augusta DA, Beckwith K, Morris EA (2000) Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rh-BMP-2). J Bone Joint Surg Am 82:151-160
139. Grgic M, Jelic M, Basic V, Basic N, Pecina M, Vukicevic S (1997) Regeneration of articular cartilage defects in rabbits by osteogenic protein-1 (bone morphogenetic pro-tein-7). Acta Med Croatica 51:23-27
140. Cook SD, Patron LP, Salkeld SL, Rueger DC (2003) Repair of articular cartilage defects with osteogenic protein-1 (BMP-7) in dogs. J Bone Joint Surg Am 85-A Suppl 3:116-123
141. Gelse K, von der Mark K, Aigner T, Park J, Schneider H (2003) Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthritis Rheum 48:430-441
142. Yamaguchi A (1995) Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-beta superfamily. Semin Cell Biol 6:165-173
143. Galera P, Redini F, Vivien D, Bonaventure J, Penfornis H, Loyau G, Pujol JP (1992) Effect of transforming growth factor-beta 1 (TGF-beta 1) on matrix synthesis by mono-layer cultures of rabbit articular chondrocytes during the dedifferentiation process. Exp Cell Res 200:379-392
144. Na K, Kim S, Sun BK, Woo DG, Yang HN, Chung HM, Park KH (2008) Bioimaging of dexamethasone and TGF beta-1 and its biological activities of chondrogenic differentiation in hydrogel constructs. J Biomed Mater Res A (in press)
145. Yaeger PC, Masi TL, de Ortiz JL, Binette F, Tubo R, McPherson JM (1997) Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes. Exp Cell Res 237:318-325
146. Worster AA, Brower-Toland BD, Fortier LA, Bent SJ, Williams J, Nixon AJ (2001) Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-beta1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res 19:738-749
147. Guo CA, Liu XG, Huo JZ, Jiang C, Wen XJ, Chen ZR (2007) Novel gene-modifed-tissue engineering of cartilage using stable transforming growth factor-beta1-transfected mesenchymal stem cells grown on chitosan scaffolds. J Biosci Bioeng 103:547-556
148. Lima EG, Bian L, Ng KW, Mauck RL, Byers BA, Tuan RS, Ateshian GA, Hung CT (2007) The benefcial effect of delayed compressive loading on tissue-engineered cartilage constructs cultured with TGF-beta3. Osteoar-thritis Cartilage 15:1025-1033
149. Benjamin A, Byers RLM, Chiang IE, Tuan RS (2008) Transient exposure to TGF-β3 under serum-free conditions enhances the biomechanical and biochemical maturation of tissue-engineered cartilage. Tissue Engineering (in press)
150. Bianco P, Riminucci M, Kuznetsov S, Robey PG (1999) Multipotential cells in the bone marrow stroma: regulation in the context of organ physiology. Crit Rev Eu-karyot Gene Expr 9:159-173
151. Bianco P, Gehron Robey P (2000) Marrow stromal stem cells. J Clin Invest 105:1663-1668
152. Friedenstein AJ, Latzinik NW, Grosheva AG, Gorskaya UF (1982) Marrow microenvironment transfer by het-erotopic transplantation of freshly isolated and cultured cells in porous sponges. Exp Hematol 10:217-227
153. Song L, Webb NE, Song Y, Tuan RS (2006) Identifca-tion and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipo-tency. Stem Cells 24:1707-1718
154. Song L, Tuan RS (2004) Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 18:980-982
155. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F (2005) Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105:2821-2827
156. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noel D, Jorgensen C (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102:3837-3844
157. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F (2003) Bone marrow mesenchy-mal stem cells inhibit the response of naive and memory antigen-specifc T cells to their cognate peptide. Blood 101:3722-3729
158. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM (2002) Human bone marrow stromal cells suppress T-lympho-cyte proliferation induced by cellular or nonspecifc mi-togenic stimuli. Blood 99:3838-3843
159. Djouad F, Bony C, Haupl T, Uze G, Lahlou N, Louis-Plence P, Apparailly F, Canovas F, Reme T, Sany J, Jorgensen C, Noel D (2005) Transcriptional profles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 7:R1304-R1315
160. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM,
161. Nakahara H, Goldberg VM, Caplan AI (1991) Culture-expanded human periosteal-derived cells exhibit osteo-chondral potential in vivo. J Orthop Res 9 465-76.
162. Noel D, Djouad F, Jorgense C (2002) Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr Opin Investig Drugs 3:1000-1004
163. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesen-chymal stem cells. Exp Hematol 31:890-896
164. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Mo-seley AM, Deans R, Marshak DR, Flake AW (2000) Human mesenchymal stem cells engraft and demonstrate site-specifc differentiation after in utero transplantation in sheep. Nat Med 6:1282-1286
165. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIn-tosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48
166. Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, Haynesworth SE, Koc ON (2004) Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33:597-604
167. Potian JA, Aviv H, Ponzio NM, Harrison JS, Ramesh-war P (2003) Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171:3426-3434
168. Gotherstrom C, Ringden O, Westgren M, Tammik C, Le Blanc K (2003) Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 32:265-272
169. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75:389-397
170. Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, Deans RJ, McIntosh KR (2005) T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 12:47-57
171. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Ga-zit Z, Aslan H, Galun E, Rachmilewitz J (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214-2219
172. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-di-oxygenase-mediated tryptophan degradation. Blood 103:4619-4621
173. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S, Annunziato F (2006) Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386-398
174. Jones BJ, Brooke G, Atkinson K, McTaggart SJ (2007) Immunosuppression by placental indoleamine 2, 3-di-oxygenase: a role for mesenchymal stem cells. Placenta 28:1174-1181
175. Baksh D, Yao R, Tuan RS (2007) Comparison of pro-liferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384-1392
176. Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506
177. Fallarino F, Grohmann U, Vacca C, Orabona C, Spreca A, Fioretti MC, Puccetti P (2003) T cell apoptosis by kynurenines. Adv Exp Med Biol 527:183-190
178. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bo-nanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A (2005) Mesenchymal stem cells ameliorate experimental autoimmune encepha-lomyelitis inducing T-cell anergy. Blood 106:1755-1761
179. Plumas J, Chaperot L, Richard MJ, Molens JP, Bensa JC, Favrot MC (2005) Mesenchymal stem cells induce apop-tosis of activated T cells. Leukemia 19:1597-1604
180. Stephens LA, Barclay AN, Mason D (2004) Phenotypic characterization of regulatory CD4+CD25+ T cells in rats. Int Immunol 16:365-375
181. Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F (2004) Nonantigen spe-cifc CD8+ T suppressor lymphocytes originate from CD8+CD28-T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol 65:142-156
182. Filaci G, Fravega M, Fenoglio D, Rizzi M, Negrini S, Viggiani R, Indiveri F (2004) Non-antigen specifc CD8+ T suppressor lymphocytes. Clin Exp Med 4:86-92
183. Prevosto C, Zancolli M, Canevali P, Zocchi MR, Poggi A (2007) Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 92:881-888
184. Batten P, Sarathchandra P, Antoniw JW, Tay SS, Lowdell MW, Taylor PM, Yacoub MH (2006) Human mesenchy-mal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng 12:2263-2273
185. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822
186. Djouad F, Charbonnier LM, Bouff C, Louis-Plence P, Bony C, Apparailly F, Cantos C, Jorgensen C, Noel D (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025-2032
187. Maccario R, Podesta M, Moretta A, Cometa A, Comoli P, Montagna D, Daudt L, Ibatici A, Piaggio G, Pozzi S, Frassoni F, Locatelli F (2005) Interaction of human mes-enchymal stem cells with cells involved in alloantigenspecifc immune response favors the differentiation of CD4 + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90:516-525
188. Ramasamy R, Fazekasova H, Lam EW, Soeiro I, Lom-bardi G, Dazzi F (2007) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83:71-76
189. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57:11-20
190. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441
191. Le Blanc K, Ringden O (2005) Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11:321-334